A John Camm

A John Camm

Professor of Clinical Cardiology

St George’s University of London, UK

  • LinkedIn
  • Twitter
  • Radcliffe

Biography

Professor John Camm became Professor of Clinical Cardiology at St. George’s University of London 1986. He continues to hold this positions alongside positions as Professor of Clinical Cardiology at St George’s Hospital London and Professor of Cardiology at Imperial College London.

An internationally renowned expert in atrial fibrillation (AF), Prof Camm leads the European Network for translational research in atrial fibrillation, which works towards a better understanding of AF. Other research interests include ventricular tachycardia, cardiomyopathy, pacemakers and sudden cardiac death.

Professor Camm is a Senior Consulting Editor for the European Heart Journal and Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine. He has received numerous awards for his contributions to cardiology, including the British Cardiovascular Society Mackenzie Medal and the European Society of Cardiology Gold Medal.

Articles

Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy

C Fielder Camm, A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(2):63–8.

Letter from the New President of the European Heart Rhythm Association

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(3):107.

A Clinical Perspective on Sudden Cardiac Death

Demosthenes G Katritsis, Bernard J Gersh, A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2016;5(3):177–82

Anticoagulation in Atrial Fibrillation – Current Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2015;4(2):100–7

Early Repolarisation Syndrome – New Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2015;4(3):169–71

Inherited Arrhythmias – Where do we Stand?

A John Camm, Bernard J Gersh, Demosthenes G Katritsis,

Citation: Arrhythmia & Electrophysiology Review 2014;3(2):80–4

Stroke Prevention in Atrial Fibrillation – Outcomes and Future Directions

Katrina Mountfort, A John Camm, Gregory YH Lip,

Citation: Arrhythmia & Electrophysiology Review 2014;3(3):194–200

The Role of Continuous Monitoring in Atrial Fibrillation Management

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2014;3(1):48-50

Stroke Prevention in Atrial Fibrillation - The Unmet Need and Morbidity Burden

A John Camm,

Citation: European Cardiology 2011;7(3):187–95

Considerations for the Development of New Antiarrhythmic Drugs

A John Camm, Craig Pratt, Silvia Priori,

Citation: European Cardiology 2010;6(2 Suppl):3–7

Epidemiology and Economic Burden of Atrial Fibrillation

A Bajpai, A John Camm, I Savelieva,

Citation: US Cardiology 2007;4(1):14–7

Antidotes or Reversibility Agents – Are they Needed?

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):6-7

Once or Twice-daily NOAC Therapy – Theory and Practice

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):5

Keywords

cardiac arrhythmia, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, myocardial infarction, heart failure, cardiomyopathy